Immunosuppressive therapy in lupus nephritis: the Euro‐Lupus Nephritis Trial, a randomized trial of low‐dose versus high‐dose intravenous cyclophosphamide FA Houssiau, C Vasconcelos, D D'Cruz, GD Sebastiani, ER Garrido, ... Arthritis & Rheumatism 46 (8), 2121-2131, 2002 | 1320 | 2002 |
EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice C Dejaco, S Ramiro, C Duftner, FL Besson, TA Bley, D Blockmans, ... Annals of the rheumatic diseases 77 (5), 636-643, 2018 | 1019 | 2018 |
2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative B Dasgupta, MA Cimmino, HM Kremers, WA Schmidt, M Schirmer, ... Arthritis & Rheumatism 64 (4), 943-954, 2012 | 1016 | 2012 |
Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study M Tunca, H Ozdogan, O Kasapcopur, F Yalcinkaya, E Tutar, R Topaloglu, ... Medicine (Baltimore) 84 (1), 1-11, 2005 | 1009 | 2005 |
The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide FA Houssiau, C Vasconcelos, D D’Cruz, GD Sebastiani, ... Annals of the rheumatic diseases 69 (01), 61-64, 2010 | 600 | 2010 |
Behçet's disease: infectious aetiology, new autoantigens, and HLA-B51 H Direskeneli Annals of the rheumatic diseases 60 (11), 996-1002, 2001 | 541 | 2001 |
2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for eosinophilic granulomatosis with polyangiitis PC Grayson, C Ponte, R Suppiah, JC Robson, A Craven, A Judge, ... Arthritis & Rheumatology 74 (3), 386-392, 2022 | 485* | 2022 |
Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long‐term followup of patients in the Euro‐Lupus Nephritis Trial FA Houssiau, C Vasconcelos, D D'Cruz, GD Sebastiani, ... Arthritis & rheumatism 50 (12), 3934-3940, 2004 | 469 | 2004 |
Oral health related quality of life is affected by disease activity in Behçet's disease G Mumcu, N Inanc, T Ergun, K Ikiz, M Gunes, U Islek, S Yavuz, H Sur, ... Oral diseases 12 (2), 145-151, 2006 | 284 | 2006 |
Takayasu's arteritis in Turkey—clinical and angiographic features of 248 patients M Bicakcigil, K Aksu, S Kamali, Z Ozbalkan, A Ates, O Karadag, HTE Ozer, ... Clinical & Experimental Rheumatology 27 (1), S59, 2009 | 269 | 2009 |
Management of Takayasu arteritis: a systematic review G Keser, H Direskeneli, K Aksu Rheumatology 53 (5), 793-801, 2014 | 252 | 2014 |
British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis SL Mackie, C Dejaco, S Appenzeller, D Camellino, C Duftner, ... Rheumatology 59 (3), e1-e23, 2020 | 247 | 2020 |
Autoimmunity vs autoinflammation in Behcet's disease: do we oversimplify a complex disorder? H Direskeneli Rheumatology 45 (12), 1461-1465, 2006 | 245 | 2006 |
2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for microscopic polyangiitis R Suppiah, JC Robson, PC Grayson, C Ponte, A Craven, S Khalid, ... Arthritis & Rheumatology 74 (3), 400-406, 2022 | 237 | 2022 |
'MHC-I-opathy'—unified concept for spondyloarthritis and Behçet disease D McGonagle, SZ Aydin, A Gül, A Mahr, H Direskeneli Nature Reviews Rheumatology 11 (12), 731-740, 2015 | 237 | 2015 |
2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis C Ponte, PC Grayson, JC Robson, R Suppiah, KB Gribbons, A Judge, ... Annals of the Rheumatic Diseases 81 (12), 1647-1653, 2022 | 215 | 2022 |
The role of heat shock proteins in Behçet's disease H Direskeneli, G Saruhan-Direskeneli Clinical and Experimental Rheumatology 21 (4; SUPP/30), S44-S48, 2003 | 211 | 2003 |
Identification of multiple genetic susceptibility loci in Takayasu arteritis G Saruhan-Direskeneli, T Hughes, K Aksu, G Keser, P Coit, SZ Aydin, ... The American Journal of Human Genetics 93 (2), 298-305, 2013 | 201 | 2013 |
MEFV mutations are increased in Behçet's disease (BD) and are associated with vascular involvement P Atagunduz, T Ergun, H Direskeneli Clinical and experimental rheumatology 21 (4; SUPP/30), S35-S37, 2003 | 191 | 2003 |
Oral health is impaired in Behcet's disease and is associated with disease severity G Mumcu, T Ergun, N Inanc, I Fresko, T Atalay, O Hayran, H Direskeneli Rheumatology 43 (8), 1028-1033, 2004 | 187 | 2004 |